Estrogenic hormone action in the heart: regulatory network and function

被引:127
作者
Babiker, FA
De Windt, LJ
van Eickels, M
Grohe, C
Meyer, R
Doevendans, PA
机构
[1] Univ Hosp Maastricht, Cardiovasc Res Inst Maastricht, Dept Cardiol, NL-6202 AZ Maastricht, Netherlands
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
[3] Univ Bonn, Inst Physiol, Med Clin, D-5300 Bonn, Germany
[4] Interuniv Cardiol Inst Netherlands, Maastricht, Netherlands
关键词
atherosclerosis; coronary disease; gender; hormones;
D O I
10.1016/S0008-6363(01)00526-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular diseases are the leading cause of death in the industrialised countries and display significant gender-based differences. Estrogen plays an important role in the pathogenesis of heart disease and is able to modulate the progression of cardiovascular disease. The focus on the beneficial influence of estrogen is gradually shifting from the vascular system to the myocardium. The presence of functional estrogen receptors in the myocardium has been demonstrated. Estrogen is important for cardiovascular baseline physiology and modulates the myocardial response under pathological conditions. Here we summarise the current knowledge of the regulatory network of estrogenic action in the myocardium and its effects on cardiovascular function. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:709 / 719
页数:11
相关论文
共 119 条
  • [1] Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women
    Abu-Halawa, SA
    Thompson, K
    Kirkeeide, RL
    Vaughn, WK
    Rosales, O
    Fujisi, K
    Schroth, G
    Smalling, R
    Anderson, HV
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (04) : 409 - 413
  • [2] Initiation of hormone replacement therapy after acute myocardial infarction is associated with more cardiac events during follow-up
    Alexander, KP
    Newby, LK
    Hellkamp, AS
    Harrington, RA
    Peterson, ED
    Kopecky, S
    Langer, A
    O'Gara, P
    O'Connor, CM
    Daly, RN
    Califf, RM
    Khan, S
    Fuster, V
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (01) : 1 - 7
  • [3] QUANTITATIVE STRUCTURAL-ANALYSIS OF THE MYOCARDIUM DURING PHYSIOLOGICAL GROWTH AND INDUCED CARDIAC-HYPERTROPHY - A REVIEW
    ANVERSA, P
    RICCI, R
    OLIVETTI, G
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (05) : 1140 - 1149
  • [4] ESTROGEN ACTION VIA THE CAMP SIGNALING PATHWAY - STIMULATION OF ADENYLATE-CYCLASE AND CAMP-REGULATED GENE-TRANSCRIPTION
    ARONICA, SM
    KRAUS, WL
    KATZENELLENBOGEN, BS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) : 8517 - 8521
  • [5] The potential of SERMs for reducing the risk of coronary heart disease
    Barrett-Connor, E
    Cox, DA
    Anderson, PW
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (08) : 320 - 325
  • [6] Hormone replacement therapy, heart disease, and other considerations
    Barrett-Connor, E
    Grady, D
    [J]. ANNUAL REVIEW OF PUBLIC HEALTH, 1998, 19 : 55 - 72
  • [8] Long-term cardiovascular effects of high "osteoprotective" dose levels of 17β-estradiol in spontaneously hypertensive rats
    Blacher, J
    Dabire, H
    Pomies, JP
    Safar, ME
    Stimpel, M
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2000, 14 (03) : 303 - 307
  • [9] Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus
    Brandenberger, AW
    Tee, MK
    Lee, JY
    Chao, V
    Jaffe, RB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (10) : 3509 - 3512
  • [10] THE STUNNED MYOCARDIUM - PROLONGED, POST-ISCHEMIC VENTRICULAR DYSFUNCTION
    BRAUNWALD, E
    KLONER, RA
    [J]. CIRCULATION, 1982, 66 (06) : 1146 - 1149